LUT014 is a topical inhibitor targeting BRAF that cannot pass through the blood-brain barrier. LUT014 inhibits BRAF kinase and abnormally activates the MAPK/ERK signaling pathway, promoting the proliferation of epidermal keratinocytes, repairing skin barrier damage caused by radiation damage, and alleviating inflammatory responses. LUT014 is independent of RAS signaling and accelerates the repair and regeneration of damaged skin cells. LUT014 can be used to study radiation dermatitis, especially skin damage caused by breast cancer radiotherapy[1][2][3].
Molecular Weight:
528.49
Purity:
97.09
CAS Number:
[2274819-46-2]
Formula:
C27H19F3N8O
Target:
ERK,p38 MAPK,Raf
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
